Covid-19: Urgent Call to Action / Amal A. Mohamed, Omnia I. Tantawi, Lamiaa A. Fathalla, Dalia M. Abd El-Hassib, Naglaa El-Toukhy R. El-Toukhy, Wafaa Salah, Mahmoud Elkadeem, Omnia Ezzat, Sherief Abd-Elsalam
Novel Corona Virus 2019 (COVID-19) is a new virus spread rapidly all over the world. It has specific respiratory or gastrointestinal tract symptoms. Its reported complications include respiratory distress, systemic inflammatory response syndrome, and septic shock. Due to heavy cytokines released by the virus; corticosteroids (40-120 mg / day) were given to severe cases to reduce pneumonia. It’s a difficult task to control the spread of SARS-CoV-2, and to invent proper vaccines and treatments. In this review, the existing understanding of fatal, pandemic human coronavirus SARS-Cov2 (COVID-19), with special reference to its diagnosis, origin, transmission, and different approaches to develop its therapeutics, will be discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Anti-inflammatory & anti-allergy agents in medicinal chemistry - 20(2021), 2, Seite 5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mohamed, Amal A. [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (5 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL011144971 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011144971 | ||
| 003 | DE-627 | ||
| 005 | 20231128155914.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230613s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL011144971 | ||
| 035 | |a (KFL)prod_DARH_.E4B35B1C35F43566B70272065BF8B75F1A2B9FBE | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Mohamed, Amal A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Covid-19: Urgent Call to Action |c Amal A. Mohamed, Omnia I. Tantawi, Lamiaa A. Fathalla, Dalia M. Abd El-Hassib, Naglaa El-Toukhy R. El-Toukhy, Wafaa Salah, Mahmoud Elkadeem, Omnia Ezzat, Sherief Abd-Elsalam |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (5 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Novel Corona Virus 2019 (COVID-19) is a new virus spread rapidly all over the world. It has specific respiratory or gastrointestinal tract symptoms. Its reported complications include respiratory distress, systemic inflammatory response syndrome, and septic shock. Due to heavy cytokines released by the virus; corticosteroids (40-120 mg / day) were given to severe cases to reduce pneumonia. It’s a difficult task to control the spread of SARS-CoV-2, and to invent proper vaccines and treatments. In this review, the existing understanding of fatal, pandemic human coronavirus SARS-Cov2 (COVID-19), with special reference to its diagnosis, origin, transmission, and different approaches to develop its therapeutics, will be discussed | ||
| 700 | 1 | |a Tantawi, Omnia I. |e verfasserin |4 aut | |
| 700 | 1 | |a Fathalla, Lamiaa A. |e verfasserin |4 aut | |
| 700 | 1 | |a El-Hassib, Dalia M. Abd |e verfasserin |4 aut | |
| 700 | 1 | |a El-Toukhy, Naglaa El-Toukhy R. |e verfasserin |4 aut | |
| 700 | 1 | |a Salah, Wafaa |e verfasserin |4 aut | |
| 700 | 1 | |a Elkadeem, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Ezzat, Omnia |e verfasserin |4 aut | |
| 700 | 1 | |a Abd-Elsalam, Sherief |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-inflammatory & anti-allergy agents in medicinal chemistry |d Sharjah : Bentham Science Publ., 2006 |g 20(2021), 2, Seite 5 |h Online-Ressource |w (DE-627)KFL000006475 |w (DE-600)2227191-0 |w (DE-576)273890727 |x 1875-614X |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:2 |g pages:5 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5230&volume=20&issue=2&spage=118 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_DARH_02 | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 2 |h 5 | ||